PDMP Toolkit

 描述(申请人提供)：处方药监测计划(PDMP)是美国应对处方阿片类药物相关发病率流行的州努力的核心 和死亡率。然而，有证据表明，由于处方医生和药剂师使用不足，它们的全部潜力尚未实现。PDMP已经在49个州实施，以打击处方药滥用和提高患者安全，但由于药剂师几乎没有关于如何将PDMP整合到药房实践中的指导，PDMP尚未发挥其作为临床决策工具的潜力。该项目的长期目标是通过改善社区药剂师的技能和资源来减少与阿片类药物相关的危害，以便他们能够有效地筛选、沟通，并最终减少不安全的阿片类药物分配。为响应PA-04-002(“通过安全用药促进患者安全实施”)，本研究的目标是开发一个社区药房PDMP工具包，用于识别哪些患者的阿片类药物处方存在安全风险，在护理点与患者沟通，并与主要处方人协调，以最大限度地提高患者使用阿片类止痛药的安全性。工具包中的信息将使社区药剂师能够将PDMP整合到他们的工作流程中，识别有阿片类药物相关伤害风险的患者，处理有顾虑的患者，并协调与他们的主要处方医生的护理。中心假设是，加强PDMP在社区药房实践中的整合将导致PDMP使用的增加，并最终导致更安全的阿片类药物分配。这一假设将通过三个具体目标得到验证：本研究的第一个目标是开发PDMP工具包，包括社区药剂师如何在护理点有效使用PDMP以提高患者安全和减少阿片类药物相关伤害的政策和程序。药剂师、处方医生和患者组成的焦点小组将告知工具包的开发情况。第二个目标是在六家社区药店实施PDMP工具包，并评估该工具包对药剂师的知识、态度、自我效能和对阿片类药物分发安全性的看法的影响。第三个目标是评价PDMP工具包的实施是否导致更安全的阿片类药物使用。这个项目是创新的，因为它挑战药剂师提高他们的临床实践的目标，以提高患者的安全性和减少阿片类药物相关的伤害。完成后，开发的PDMP工具包将立即可用，并在许多社区药房环境中使用。

 DESCRIPTION (provided by applicant): Prescription drug monitoring programs (PDMPs) are a centerpiece of state efforts to confront the US epidemic of prescription opioid-related morbidity and mortality. However, evidence suggests their full potential has not been realized because of prescriber and pharmacist underuse. PDMPs have been implemented in 49 states to combat prescription drug abuse and improve patient safety, but because pharmacists have little guidance about how to integrate the PDMP into pharmacy practice, PDMPs have not their fulfilled their potential as a clinical decision tool. The long-term goal of this project is to redce opioid-related harms by improving skills and resources available to community pharmacists so they can effectively screen, communicate, and ultimately reduce unsafe opioid dispensing. In response to PA-04-002 ("Advancing Patient Safety Implementation through Safe Medication Use"), the objective of this study is to develop a community pharmacy PDMP toolkit for identifying patients for whom dispensing an opioid prescription presents a safety risk, communicating with patients at the point of care, and coordinating with the primary prescriber to maximize patient safety in the use of opioid analgesics. Information in the toolkit will enable community pharmacists to integrate the PDMP into their workflow, identify patients at risk for opioid-related harms, approach patients with concerns, and coordinate care with their primary prescribers. The central hypothesis is that enhancing the integration of PDMPs in community pharmacy practice will lead to increased PDMP use and ultimately safer opioid dispensing. This hypothesis will be tested through three specific aims: The first aim of this study is to develop th PDMP toolkit, including policies and procedures for how community pharmacists can effectively use PDMP at the point of care to increase patient safety and reduce opioid-related harms. Focus groups of pharmacists, prescribers, and patients will inform development of the toolkit. The second aim is to implement the PDMP toolkit in six community pharmacies and evaluate the impact of the toolkit on pharmacists' knowledge, attitudes, self-efficacy, and perceptions of opioid dispensing safety. The third aim is to evaluate whether implementation of the PDMP toolkit results in safer opioid use. This project is innovative because it challenges pharmacists t elevate their clinical practice with the goal of improving patient safety and reducing opioid- related harms. Upon completion, the developed PDMP toolkit will be immediately available and usable in many community pharmacy settings.